Chlamydia Tests - Medical Devices Pipeline Assessment, 2017

Published : Jun-2017

No. of Pages : 100

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 Chlamydia Tests Overview 5
3 Products under Development 6
3.1 Chlamydia Tests - Pipeline Products by Stage of Development 6
3.2 Chlamydia Tests - Pipeline Products by Territory 7
3.3 Chlamydia Tests - Pipeline Products by Regulatory Path 8
3.4 Chlamydia Tests - Pipeline Products by Estimated Approval Date 9
4 Chlamydia Tests - Pipeline Products under Development by Companies 10
4.1 Chlamydia Tests Companies - Pipeline Products by Stage of Development 10
4.2 Chlamydia Tests - Pipeline Products by Stage of Development 11
5 Chlamydia Tests Companies and Product Overview 12
5.1 Beckman Coulter Inc Company Overview 12
5.1.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 12
5.2 bioMerieux S.A. Company Overview 13
5.2.1 bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview 13
5.3 Boditech Med Inc Company Overview 14
5.3.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 14
5.4 DiaSorin S.p.A Company Overview 15
5.4.1 DiaSorin S.p.A Pipeline Products & Ongoing Clinical Trials Overview 15
5.5 Ellume Company Overview 18
5.5.1 Ellume Pipeline Products & Ongoing Clinical Trials Overview 18
5.6 Genome Diagnostics Pvt. Ltd. Company Overview 19
5.6.1 Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 19
5.7 Molbio Diagnostics Pvt. Ltd. Company Overview 20
5.7.1 Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 20
5.8 ProCelo AS Company Overview 21
5.8.1 ProCelo AS Pipeline Products & Ongoing Clinical Trials Overview 21
5.9 Queensland University of Technology Company Overview 22
5.9.1 Queensland University of Technology Pipeline Products & Ongoing Clinical Trials Overview 22
5.10 Quidel Corp Company Overview 23
5.10.1 Quidel Corp Pipeline Products & Ongoing Clinical Trials Overview 23
5.11 Sansure Biotech Inc Company Overview 24
5.11.1 Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 24
6 Chlamydia Tests - Recent Developments 25
6.1 May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 25
6.2 May 16, 2017: Akers Biosciences Announces Q1 2017 Earnings 25
6.3 May 10, 2017: Hologic Announces Financial Results for Second Quarter of Fiscal 2017 27
6.4 May 10, 2017: Meridian Bioscience Engages Korn Ferry to Conduct CEO Search as John A. Kraeutler Announces Plans to Retire 28
6.5 May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter 29
6.6 Apr 27, 2017: Meridian Bioscience Reports Second Quarter 2017 Operating Results 31
6.7 Apr 24, 2017: Quidel Reports First Quarter 2017 Financial Results 33
6.8 Apr 23, 2017: BD Announces Appointment Of Tom Polen As President 34
6.9 Apr 20, 2017: bioMerieux - First-Quarter 2017 Business Review 34
6.10 Apr 11, 2017: Akers Bioscience: Financial Results for the Year Ended December 31, 2016 37
6.11 Apr 11, 2017: Akers Biosciences Reports Earnings for Fiscal Year 2016 38
6.12 Mar 30, 2017: Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016 42
6.13 Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management 44
6.14 Mar 21, 2017: Retractable Technologies Announces Litigation Updates 45
6.15 Mar 09, 2017: Alere Provides Update on Arriva Medical 45
6.16 Feb 08, 2017: Quidel Reports Fourth Quarter and Full Year 2016 Financial Results 45
6.17 Feb 02, 2017: BD Announces Results For 2017 First Fiscal Quarter 47
6.18 Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 48
6.19 Jan 23, 2017: Quidel Announces Modification of Revenue Reporting Categories 50
6.20 Jan 19, 2017: bioMerieux - Fourth-Quarter 2016 Business Review 50
6.21 Jan 13, 2017: ProteoMediX receives ISO 13485:2012 Certification 52
6.22 Jan 06, 2017: Quidel Announces Preliminary Revenue for Fourth Quarter 2016 53
6.23 Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 53
6.24 Jan 04, 2017: Alere Laboratory Receives ABFT Accreditation 54
6.25 Jan 04, 2017: Alere Provides Update on Arriva Medical 54
6.26 Dec 28, 2016: Alere Provides Update on Arriva Medical 55
6.27 Dec 16, 2016: Amy Wendell Elected to Hologic Board of Directors 56
6.28 Dec 14, 2016: Beckman Coulter appoints IT Product Manager for Northern Europe 56
6.29 Dec 08, 2016: Khang & Khang Announces Securities Class Action Lawsuit against Alere and Reminds Investors with Losses to Contact the Firm 57
6.30 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition 57
6.31 Nov 14, 2016: Akers Biosciences Announces Q3 Earnings 57
6.32 Nov 10, 2016: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results 59
6.33 Nov 10, 2016: Diasorin Group Reports Continued Growth In Revenues And Profitability In The Third Quarter 2016 61
6.34 Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux 62
6.35 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results 62
6.36 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 63
6.37 Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016 65
6.38 Oct 26, 2016: Quidel Reports Third Quarter 2016 Financial Results 66
6.39 Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016 68
6.40 Oct 18, 2016: Meridian Bioscience Comments on Preliminary Fiscal 2016 Operating Results and Provides Fiscal 2017 Revenue and Earnings Guidance 70
6.41 Oct 03, 2016: Bioline is Certified to the ISO 13485 Quality Standard 72
6.42 Sep 06, 2016: Alere Reports Second Quarter 2016 Financial Results 72
6.43 Aug 31, 2016: bioMerieux - First-Half 2016 Results 73
6.44 Aug 17, 2016: Alere Reports First Quarter 2016 Financial Results 77
6.45 Aug 11, 2016: Akers Biosciences Announces H1 and Q2 2016 Earnings 78
6.46 Aug 08, 2016: Alere Files Form 10-K, Reports Fourth Quarter and Full Year 2015 Financial Results 79
6.47 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 81
6.48 Aug 04, 2016: Diasorin Group Revenues And EBITDA Reached Record highs In the Second Quarter 2016 83
6.49 Jul 28, 2016: BD Names R. Andrew Eckert To Board Of Directors 87
6.50 Jul 28, 2016: Cepheid Reports Second Quarter 2016 Results 87
6.51 Jul 28, 2016: Meridian Bioscience Reports Third Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Updates Fiscal 2016 Guidance 88
6.52 Jul 27, 2016: Hologic Announces Financial Results for Third Quarter of Fiscal 2016 90
6.53 Jul 27, 2016: Quidel Reports Second Quarter 2016 Financial Results 92
6.54 Jul 18, 2016: bioMerieux - Second-Quarter 2016 Business Review 93
7 Appendix 97
7.1 Methodology 97
7.2 About GlobalData 100
7.3 Contact Us 100
7.4 Disclaimer 100

1.1 List of Tables
Table 1: Chlamydia Tests - Pipeline Products by Stage of Development 6
Table 2: Chlamydia Tests - Pipeline Products by Territory 7
Table 3: Chlamydia Tests - Pipeline Products by Regulatory Path 8
Table 4: Chlamydia Tests - Pipeline Pro

1.2 List of Figures
Figure 1: Chlamydia Tests - Pipeline Products by Stage of Development 6
Figure 2: Chlamydia - Pipeline Products by Territory 7
Figure 3: Chlamydia Tests - Pipeline Products by Regulatory Path 8
Figure 4: Chlamydia Tests - Pipeline Products by Estimated Approval Date 9

Filed in: Pharmaceutical

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027 “The ambulatory EHR market is projected to grow at a CAGR of 6.1% between 2022 and 2027.” The global ambulatory EHR market is projected to reach USD 5.7 billion in 2022 to USD 7.7 billion by 2027, at a CAGR of 6.1%during the forecast period. Growth in this market is driven by the opportunities provided by the market such as increasing demand for cloud-based ambulatory EHR market, and shift towards patient-centric healthcare delivery. However, the interoperability issues & data security concerns are some of the challenges that are expected to limit the growth of the market to a certain extent during the forecast period. “Cloud-based was the fastest-growing segment in the delivery mode of ambulatory EHR market in 2021” Cloud-based segment is projected to growth at the hi......	$4950
Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027 “The pharmaceutical excipients market growth can be attributed to factors such as the rising pharmaceuticals market, advancements in functional excipients, and the growing generics market. The rapidly growing biopharmaceuticals sector will also influence market growth..” The pharmaceutical excipients market is projected to reach USD 11.5 Billion by 2027 from USD 8.6 Billion in 2022, at a CAGR of 5.9% during the forecast period.The growth can be attributed to the expanding pharmaceutical industry which has fueled the drug production thereby increasing consumption rate for excipients. Additionally, factors like functional excipients development and upsurge in generics market is also likely to propel market growth. “The fillers & diluents functionality accounted for the larges......	$
Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027 “Digital Pharmacy market to register a CAGR of 17.0% during the forecasts period The digital pharmacy market is expected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the growing consumer preference toward buying online medicines during and post COVID-19 pandemic, consolidation in the market and partnerships, and increasing geriatric population. However, patients relying on pharmacists for clinical support and increasing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period. “Over-the-counter (OTC) products segment is estimated to grow at the highest rate during the forecast period” On the basis ofdrug type, t......	$4950
Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027 The pharmacy automation market is expected to grow at a CAGR of 7.9% in the forecast period. The pharmacy automation market is projected to reach USD 8.2 billion by 2027 from USD 5.6 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth in this market is attributed to the growing need to minimize medication errors, rapid decentralization of pharmacies, and growing focus on automation to reduce labor costs. However, the stringent regulations that delay product launches can inhibit the growth of this market. Based on product, the automated medication dispensing and storage systems segment holds the largest market share in 2021 Based on products, the pharmacy automation market is segmented into automated medication dispensing and storage systems, automated packagi......	$4950
Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027 The topical drug delivery market is expected to grow at a CAGR of 8.9% in the forecast period. The global topical drug delivery market is projected to reach USD 317.8 billion by 2027 from USD 207.4 billion in 2022, at a CAGR of 8.9%. The growth of this market can largely be attributed to the high prevalence of topical prescription therapy for dry eye diseases, growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems, increase in prevalence of central nervous disorders, rising preference for non-invasive drug delivery methods. “The semi-solid formulation segment accounted for the largest share of the topical drug delivery market, based on product in 2021.” Based on products, the topical drug delivery the market is segmented into ......	$4950
Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026 “Increasing incidence and prevalence of neurological disorders is a key factors driving growth in the cognition and memory enhancement market’’ The global cognition and memory enhancement market is projected to reach USD 38.9 billion by 2026 from USD 23.4 billion in 2021, at a CAGR of 10.7% during the forecast period. Elevating prevalence of neurological disorders, such as dementia, epilepsy, Parkinson’s disease, Huntington’s disease, headache disorders, multiple sclerosis, neuroinfections, stroke, and cerebral palsy, have increased significantly over the years. “By product & service segment, the cognition & memory-enhancing drugs segment has registered fastest growth rate during the forecast period” Based on product & service, the cognition and memory en......	$4950
High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027 The HPAPI market is projected to reach USD 39.6 Billion by 2027 from USD 24.5 billion in 2022, at a CAGR of 10.1% from 2022 to 2027. The market is driven by increasing demand for oncology drugs, growing demand for antibody-drug conjugates and others. “The innovative HPAPIs segment is expected to account for the largest share of the market in 2021” Based on type, the HPAPI market is segmented into innovative and generic. The innovative segment is expected to account for the largest share of the HPAPI market in 2021. The large share can be attributed to the increased R&D investments. “The Synthetic APIs segment to account for the largest share of the market in 2021” Based on type of synthesis, the market is segmented into synthetic and biotech HPAPIs. The synthetic AP......	$4950
Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027 “Increased risk of communicable diseases, Rising prevalence of bleeding disorders in global population, Use of Immunoglobulin’s for a range of neurological conditions, including multiple sclerosis, neuropathic pain, and chronic fatigue syndrome is expected to drive the overall growth of the plasma fractionation market.” The global plasma fractionation market size is projected to reach USD 36.7 billion by 2027 from USD 26.5 billion in 2022, at a CAGR of 6.7% during the forecast period. Market growth is driven mainly by factors such as rapid growth of geriatric population, growing prevalence of respiratory disorders such as alpha-1-antitrypsin deficiency (AATD) and emphysema, and use of plasma fractionation products as first-line therapies for a number of bleeding, hematological, an......	$4950
Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027 “Patient engagement solutions market to register a CAGR of 10.0% from 2022 to 2027” The patient engagement solutions market is projected to reach USD 27.9 billion by 2027 from USD 17.3 billion in 2022, at a CAGR of 10.0% during the forecast period. The growth of this market is driven by the adoption and changes in government regulations to promote patient-centric care and involve patients throughout the care journey, high demand for patient engagement solutions, and the growing utilization of m- health apps. However, interoperability issues for patient engagement solutions and a dreadth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period. “Services segment is expected to grow at the highest rate......	$4950
Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027 The global Healthcare cloud computing market is projected to reach USD 89.4 billion by 2027 from USD 39.4 billion in 2022, at a CAGR of 17.8%. The factors driving the market are adoption of technologies like telehealth, EHR, big data analytics, IoT, cloud computing, m health, wearlable devices, etc. “The healthcare provider solution was the largest segment in the healthcare cloud computing market in 2021.” The healthcare provider segment accounted for the larger share of 79.2% of the healthcare cloud computing market in 2021. The growing adoption of various health IT solutions such as EHR, e-prescribing, telehealth, mHealth, and others due to COVID-19 is one of the key factors contributing to the growth of this segment. “Among end users, the healthcare providers segment ac......	$4950

Chlamydia Tests - Medical Devices Pipeline Assessment, 2017

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

Ambulatory EHR Market by Delivery Mode (Cloud-based, On-premise), Application (e-Prescribing, PHM, Health Analytics, Practice, Patient & Referral Management), Practice Size (Large, Small-to-Medium, Solo), End User (Independent) – Global Forecast to 2027

Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) – Global Forecast to 2027

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027

Pharmacy Automation Market by Product (Automated Medication Dispensing & Storage Systems, Table-Top Counters, Retrieval Systems, Medication Compounding), End User (Inpatient, Outpatient (Fast-Track Clinics), Retail Pharmacies) – Global Forecast to 2027

Topical Drug Delivery Market by Type (Semi-solids (Creams, Gels, Lotions), Solids(Suppositories), Liquids(Solutions), Transdermal products), Route(Dermal, Ophthalmic), Facility of Use (Homecare setting, Hospitals, Burn Centres) – Global Forecast to 2027

Cognition and Memory Enhancement Market by Product & Service (Cognition & Memory-enhancing Drugs, Brain-boosting Nutraceuticals, Cognitive Assessment & Training Solutions), Region (North America, Europe, Asia Pacific, ROW) – Global Forecast to 2026

High Potency APIs/HPAPI Market by Type (Innovative, Generic), Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), Manufacturers (Captive, Merchant), Application (Oncology, Hormonal Imbalance, Glaucoma) Region – Global forecast to 2027

Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology, Immunology, Hematology, Rheumatology), End User (Clinical Research, Hospitals & Clinics) – Global Forecast to 2027

Patient Engagement Solutions Market by Component (Software, Services), Delivery (On-Premise, Cloud), Therapy Area (CVD, Diabetes, Obesity, Fitness), Functionality (E-prescribing, Virtual care), End User (Provider, Payer, Patients) – Global Forecast to 2027

Healthcare Cloud Computing Market by Product (EMR/EHR, VNA, RIS, LIS, PIS), Deployment (Private Cloud, Hybrid Cloud, Public Cloud), Component (Software, Services), Pricing (Spot Pricing), Service (SaaS, IaaS, PaaS), End User – Global Forecasts to 2027